Definitive Healthcare Corp. (NASDAQ:DH) Q2 2024 Earnings Conference Call August 5, 2024 5:00 PM ET

Company Participants

Matt Ruderman - Investor Relations
Kevin Coop - Chief Executive Officer
Rick Booth - Chief Financial Officer

Conference Call Participants

Saket Kalia - Barclays
Craig Hettenbach - Morgan Stanley
Joe Vruwink - Baird
David Grossman - Stifel
Matt Shea - Needham & Company
Hanna Lee - Bank of America
John McCary - Raymond James
Jared Haase - William Blair

Operator

Welcome to Definitive Healthcare’s Q2 2024 Earnings Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session.

I would now like to turn the call over to Matt. Please go ahead.

Matt Ruderman

Good afternoon. And thank you for joining us today to review Definitive Healthcare’s financial results. Joining me on the call today are Kevin Coop, Chief Executive Officer; and Rick Booth, Chief Financial Officer.

During this call, we will make forward-looking statements, including but not limited to statements related to our market and future performance and growth opportunities, the benefits of our healthcare commercial intelligence solutions, our competitive position, customer behaviors and use of our solutions, our financial guidance, our planned investments, generating value for our customers and shareholders, and the anticipated impacts of global macroeconomic conditions on our business, results, and customers, and on the healthcare industry generally. Any forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

Forward-looking statements involve a number of risks and uncertainties, including those discussed in the risk factor sections and elsewhere in our filings with the SEC. Actual results may differ materially from any forward-looking statements. The company undertakes no obligation to revise or update any forward-looking statements to reflect events that may arise after this conference call, except as required by law. For more information, please refer to the cautionary statement included in the earnings release that we have just posted to the Investor Relations portion of our website.

Additionally, we will discuss non-GAAP financial measures on this conference call. Please refer to the tables in our earnings release and investor presentation on the Investor Relations portion of our website for a reconciliation of these measures to their most directly comparable GAAP financial measure.

With that, I’d like to turn the call over to Kevin.

Kevin Coop

Thanks, Matt. And thanks to all of you for joining us this afternoon to review Definitive Healthcare’s second quarter 2024 financial results. Let me begin by saying I’m very excited and energized to be the new CEO of Definitive Healthcare, and I look forward to meeting with many of you in the days and weeks ahead.